Microspheres have been prepared from the resorbable linear polyester of β-hydroxybutyric acid (polyhydroxybutyrate, PHB) by the solvent evaporation technique and investigated in vitro and in vivo. Biocompatibility of the microspheres has been proved in tests in the culture of mouse fibroblast cell line NIH 3Т3 and in experiments on intramuscular implantation of the microspheres to Wistar rats for 3 months. Tissue response to the implantation of polymeric microspheres has been found to consist in a mild inflammatory reaction, pronounced macrophage infiltration that increases over time, involving mono-and poly-nuclear foreign body giant cells that resorb the polymeric matrix. No fibrous capsules
Introduction
Designing of controlled-release drug delivery systems is a promising and rapidly developing line of pharmacology. The main advantage of using drug delivery systems is that drug concentration in a patient's blood and/or tissues can be maintained at a target level for an extended time (Amass et al., 1998; Kost and Langer, 2001) . The most promising drug delivery systems seem to be biodegradable microspheres and microcapsules, which can be used to deliver a wide range of drugs; they can be injected into the bloodstream, subcutaneously, and intramuscularly and adapted for oral administration or inhalation (Freiberg and Zhu, 2004) . The principal requirement for fabricating prolonged-action controlled-release drug delivery systems is availability of an appropriate material, which must be absolutely harmless to an organism and possess the necessary physical-mechanical and biomedical properties, including degradability in biological media. At the present time, the most widely used and actively developed bioresorbable materials are polymers of monocarboxylic acid derivatives (polylactides and polyglycolactides), which have recently been joined by linear polyesters of microbiological origin -polyhydroxyalkanoates (PHAs) (Amass et al., 1998; S. Williams and Martin, 2002) .
It has been shown that PHAs can be used to fabricate various items for medicine: surgery, transplantology, tissue engineering, and pharmacology (Anderson, 1988 (Anderson, , 1997 . One of the main tasks facing those investigating new biomaterials is to prove that they are absolutely biocompatible with and harmless to the host organism. Some researchers investigating PHAs such as polyhydroxybutyrate (PHB) and hydroxybutyrate/hydroxyvalerate copolymers (PHB/PHV) reported their cytotoxicity in animal cell cultures in vitro (Freiberg and Zhu, 2004) and slight inflammatory and pyrogenic reactions in animals during in vivo experiments (Gogolewski et al., 1993b) . In recent years in vivo studies were conducted to evaluate biocompatibility of new PHAs (incorporating hydroxyhexanoate) (Qu et al., 2006) . However, inflammation and other undesirable reactions to the tested biomaterials can also be related to their chemical composition, a particular implantation site, and the degree of chemical purity of the material.
Literature reports show that it is not uncommon to use commercially available polymers in biomedical studies of PHAs (Williams et al., 1999) . The level of endotoxins in them can reach 120 U/g (Sadian et al., 2000; Sevastianov et al., 1990) due to the presence of microbial cell debris, which contains lipopolysaccharides and other complexes capable of causing negative reactions in cells in the in vitro systems and pyrogenic reactions in vivo (Sevastianov, 1990; Dobrova et al.,1991 (Stasishina avd Volova, 1996) , tissue (Volova and Kalacheva, 1996a) , and organism (Volova et al., 1996b) levels.
The biocompatibility of polyhydroxybutyrate (PHB, the most widespread and best studied PHA)
has been confirmed in vitro, in cultures of cells of various origins (Volova, 2004; Saad et al., 2000; Shishatskaya et al., 2004a) . Rather few results have been reported on in vivo biocompatibility of PHB, including data on local tissue reaction to polyhydroxybutyrate and poly(hydroxybutyrate/ hydroxyvalerate) implants (Gogolewski et al., 1993b; Shishatskaya and Volova, 2004b) .
However, those investigations were performed using large implants, in the form of sutures, film grafts or pins (Williams and Martin, 2002; Qu et al., 2006) . It is well-known, though, that biocompatibility of biomaterials depends not only on the chemical structure and purity of the specimens but, to a large extent, on the size and shape of the implant (Anderson and Shive, 1997) .
Microspheres are considered to be the best form for injection-delivered prolonged-action drugs. However, microspheres, though containing a small amount of biomaterial, have a large surface area and, being injected subcutaneously or intramuscularly, come in contact with extensive area inside the host organism, which can cause stronger tissue reaction (Anderson and Shive, 1997; Vospaleniye, 1995) . (Sevastianov et al., 2003) . The trademark of the material is Bioplastotan (Trademark "BIOPLASTOTAN".
Registration Certificate № 315652).
Preparation of microspheres
PHA-based microspheres were prepared by the solvent evaporation technique, using a collected by centrifuging (at 10 000 rpm, for 5 min), rinsed 7-8 times in distilled water, and freeze dried in an LS-500 lyophilic dryer (Russia).
Microspheres characterization
The size (number and volume weight mean diameter) and the size distribution of microspheres suspended in water were determined with an optical particle sizer Particle counter CASY TTC (Scharle system GmbH, Germany). Water was used as eluent. The microstructure of film surfaces was analyzed by electron microscopy.
The samples were placed on the microscopic stage, coated with carbon and aluminum in a JEE-4C vacuum evaporator and studied using a JEM-100C electron microscope with an EM-ASID-4 raster attachment (Japan).
In vitro cytotoxicity of microspheres
After sterilization, microspheres were tested for cytotoxicity towards the growth, morphology 
Results and Discussion

Microspheres characterization
The microspheres were of regular spherical shape and had a well-developed "wrinkled" porous surface; their diameters were significantly heterogeneous (Fig. 1) . The size distribution of the microspheres injected intramuscularly in the rats was as follows (Fig. 2) . The fraction 
In vivo reaction
All animals in the treatment group, which had been injected with a microspheres suspension, were healthy and ate well. Their body mass and masses of their internal organs were similar to those of the rats in the control group.
At 24 h after the injection of polymeric microparticles, the microscopic picture at the injection site was characterized by a slight tissue which prevents the formation of granulation tissue (Marchant et al., 1983; Zhao et al., 1992; Kao et al., 1994) . When biodegradable materials are implanted, the macrophage response, which follows the neutrophil response, increases rather than decreases. The reason for this is that macrophages and foreign body giant cells phagocytize and resorb biodegradable materials. (Kang and Singh, 2005) , and poly(methylidene malonate 2.1.2 (Fournier, et al., 2006) .
It has been reported that in some PHAs, including 3-and 4-polyhydroxybutyrate, in vivo resorption involves active participation of phagocytic macrophages and foreign body giant cells (FBGCs) (Williams and Martin, 2002) . In our recent study we investigated tissue response to polyhydroxybutyrate monofilament sutures used to close muscle-fascial wounds and found out that macrophages played an important role in the tissue repair response, phagocytizing injured cells and tissues and polymer particles and degradation products (Shishatskaya et al., 2004a) .
The reaction of tissues to polyhydroxybutyrate implants was comparable in intensity and length to their reaction to silk and was considerably less pronounced than their reaction to resorbable catgut. by fibroblast infiltration and the development of blood capillaries (Anderson, 1988 (Shishatskaya et al., 2004a) . At 2 weeks, the cluster of the injected microspheres was encapsulated with thin connective tissue (Fig. 3) . At that time, the percentage of large particles (over 10-15μm) in the cluster of microspheres was significantly reduced and did not exceed 14% in the field of view. Active fibroblast elements were identified in the structure of the thin capsule; its mean thickness was not more than 50-60 μm; it consisted of 4-6 fibroblast layers. The reaction was almost 3 times less intensive than the reaction of muscular tissue to the implantation of sutures that we reported earlier (Shishatskaya et al., 2004a) . This result is in good agreement with the data reported by Fournier et al. (Fournier et al., 2006) , who found that the intramuscularly injected microspheres cluster was isolated from the muscular tissue by a very thin fibrous capsule, which was much less At 5 weeks, the number of mono-and polynuclear macrophages at the site of implantation of the microspheres increased (Fig. 4a) . The fraction of large particles became smaller and did not exceed 4-5% of the total amount of the particles in the field of view, suggesting that the polymeric matrix was being degraded. FBGCs with 6-8 nuclei were observed to aggregate around large (more than 10 μm in diameter) microspheres. At the interface between the intact muscular tissue and the microspheres there still was a fibrous capsule, though very thin, consisting of 2-3 layers of mature fibroblasts (Fig. 4b) . The macrophage response grew more intense at 7-9 weeks; the number of FBGCs increased and so did the number of their nuclei. At the site of implantation of the microspheres we clearly saw macrophages grouped around large microparticles. In some cases
we could see penetration of cell elements into the surface matrix of the microspheres and degraded (resorbed) parts around the circumference of the particles at the implant/tissue interface (Fig. 5a ), which indicated that the polymeric matrix of the microparticles was being degraded. There were no fibrous capsules either at the microspheres/tissue interface or around any of the microspheres. This is a very important fact because the fibrous capsule around a polymeric particle could significantly influence the release behavior of the encapsulated drug and resorption of the polymeric matrix.
At the end of the experiment (11-12 weeks), the tissue reaction remained essentially the same:
we observed pronounced macrophage infiltration with a large number of poly-nuclear FBGCs, which either surrounded polymeric particles or were grouped around a cluster of smaller microparticles; there were rather large fusions of
FBGCs with 10-12 and even more nuclei (Fig. 5a ). There were no fibrous capsules at the interface between the intact muscular tissue and the cluster of the microspheres. In some parts of the microspheres cluster there was polymeric detritus, as a degradation product of larger particles. The fraction of microspheres larger than 10-15 μm in the field of view significantly decreased (to about 2-3%) and fragmented microparticles were seen (Fig. 5b ). For quite a long time, however, most of the microspheres persisted in the tissue undegraded, suggesting that in vivo bioresorption of microparticles must be rather a long process, which makes polyhydroxybutyrate a good candidate for fabricating a prolonged-action drug form intended for intramuscular injection. 
